Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
Celestica Inc.'s Chief Human Resources Officer reported several equity transactions in company common shares on 12/01/2025. The officer acquired 6,802 common shares at an exercise price of $0 through the vesting and settlement of restricted share units (RSUs), increasing directly held shares before subsequent transactions.
To cover tax withholding arising from the RSU vesting, 3,642 shares were withheld and disposed of at $323.38 per share, and an additional 3,160 shares were sold at the same price. After these transactions, the officer directly owned 13,892 common shares and held no remaining RSUs from this grant.
Celestica Inc. reported an insider equity transaction by its President. On 12/01/2025, the officer acquired 17,792 common shares through the vesting and settlement of restricted share units at an exercise price of $0, increasing directly held shares. On the same date, 8,248 common shares were disposed of at $344.41 per share to cover tax withholding obligations tied to the RSU vesting. Following these transactions, the officer directly owned 108,970 common shares. The underlying RSU award covered 17,792 common shares and was fully settled, leaving no derivative securities from that grant outstanding.
Celestica Inc. Chief Operations Officer reports RSU vesting, tax withholding, and share sale. On 12/01/2025, 17,792 common shares were acquired at an exercise price of $0 upon the vesting and settlement of restricted share units (RSUs). On the same date, 8,605 of these shares were disposed of at $323.38 per share to cover tax withholding obligations, and 9,187 shares were sold in a market transaction at $323.38 per share, leaving 0 common shares held directly after these transactions.
These activities relate to an RSU grant of 53,375 units awarded on January 31, 2023, which vests ratably over three years, including on December 1 following the second anniversary of the grant date. Each RSU represents a contingent right to receive one common share or an equivalent cash amount at the holder’s election.
Celestica Inc. insider plans to sell common shares under Rule 144. A notice reports a proposed sale of 3,160 common shares through broker Canaccord Genuity on the NYSE, with an aggregate market value of 1,088,335.60. The filing notes that 115,036,621 shares of the issuer were outstanding. The shares to be sold were acquired on 12/01/2025 through the vesting of restricted share units from Celestica Inc., with the same date listed for acquisition and payment.
Celestica Inc. insider filed a Form 144 notice to sell up to 9,186 common shares through broker Canaccord Genuity on the NYSE, with an approximate sale date of 12/01/2025. The filing lists an aggregate market value of these shares of $3,163,750.26. The 9,186 shares were acquired on 12/01/2025 through restricted share unit vesting from Celestica Inc. Shares outstanding were 115,036,621 at the time referenced, providing context for the size of this planned sale.
Celestica (CLS) reported a director’s open‑market purchases on 10/30/2025. The filing lists four buy transactions totaling 6,000 common shares, at weighted average prices of $339.68 (700 shares), $340.55 (600), $341.96 (3,227), and $342.44 (1,473). Following these trades, the director beneficially owns 6,000 shares, held directly. No derivative securities were reported.
Celestica Inc. (CLS) announced final acceptance from the Toronto Stock Exchange for a normal course issuer bid to repurchase up to 5,722,527 common shares, representing approximately 5 percent of the outstanding public float as of October 20, 2025. The NCIB will run from November 3, 2025 to November 2, 2026. The company furnished the related press release as Exhibit 99.1.
Celestica Inc. (CLS) — Form 3 initial ownership filing
A newly reported director filed a Form 3 reflecting their status under Section 16. As of the event date 10/27/2025, the filing states no securities are beneficially owned. The form was submitted by an attorney‑in‑fact pursuant to a Power of Attorney (Exhibit 24.1) and indicates it was filed by one reporting person.
Celestica Inc. (CLS) appointed Laurette T. Koellner to its Board of Directors, effective October 27, 2025. The Board determined she is an independent director under Canadian securities laws and NYSE listing standards.
Koellner will serve on the Audit, Human Resources and Compensation, and Nominating and Corporate Governance committees. She previously served on Celestica’s Board before stepping down in January 2025 and returns with senior leadership experience at International Lease Finance Corporation and The Boeing Company. She will be compensated according to existing Board director policies.
Celestica Inc. (CLS) furnished an Investor and Analyst Day presentation under Item 7.01. On October 28, 2025, the company posted the deck on its investor website for use during its conference call covering results for the quarter ended September 30, 2025 and Investor and Analyst Day. The presentation is included as Exhibit 99.1.
The information provided under Item 7.01, including Exhibit 99.1, is furnished and not filed under the Exchange Act.